medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2000, Number 2

<< Back Next >>

Cir Gen 2000; 22 (2)

Experience in the management of colo-rectal cancer in the Centro Médico Nacional de Occidente (National Medical Center of the West)

Durán RO, González OA, Cisneros LFJ, Hermosillo SJM

Language: Spanish
References: 28
Page: 153-158
PDF size: 77.03 Kb.


ABSTRACT

Introduction: Colorectal cancer is one of the most frequently observed visceral cancers in Mexico. Therefore, the patients affected by this pathology must be included in an adequate study protocol, which will allow to analyze the main factors related to the pathology and response to the different types of established treatment procedures.
Objective: To inform the results of medical and surgical treatment of consecutive patients with colon and rectum carcinoma.
Design: Retrospective, transversal study.
Setting: Third level health care hospital.
Patients and methods: Two-hundred patients with histologically confirmed colorectal carcinoma and treated surgically were included in this study, from January 1984 to December 1998. All patients had available clinical records and were staged according to the TNM classification. Survival was calculated according to the Kaplan and Meier methods.
Results: From the 200 patients, 102 (51%) were men and 98 (49%) were women; 61% were under 60 years of age. Cancer was localized in the rectum in 66% of the cases. Resection of the affected colon segment, re-establishing intestinal transit, was the most frequently performed procedure (110 patients). The most frequent type was adenocarcinoma (95% of all cases). In 83 patients (44%) cancer was in stage III and in 27 (14%) in stage IV. The most frequent postoperative complication was infection of the surgical wound, in 8% of the patients. Actuarial survival at 5 years is 90% for stage I, 65% for stage II, and 30% for stage III. Adjuvant chemotherapy was used in 51% of the patients, and only 8% were subjected to palliative treatment combined with a derivation stoma. Operative mortality was of 5%.
Conclusion: Young persons are not excluded from colon and rectal cancer. It is still being diagnosed in advanced stages in Mexico. The best results with treatment are obtained when the colorectal cancer is diagnosed in early stages and treated adequately with surgical resection and adjuvant therapy.


REFERENCES

  1. Silverberg E. Boring CC, Squirer TS. Cancer statistics, 1990. CA. Cancer J Clin 1990; 40: 9-26.

  2. Milsom JW. Pathogenesis of colorectal cancer. Surg Clin North Am 1993; 73: 1-12.

  3. Baba S. Recent advances in molecular genetics of colorectal cancer. World J Surg 1997; 21: 678-87.

  4. Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D?. Am J Clin Nutr 1991; 54(1 Suppl): 193S-201S.

  5. Lipkin M, Newmark H, Boone CW, Kelloff GJ. Calcium, vitamin D, and colon cancer. Cancer Res 1991; 51: 3069-70.

  6. Nelson RL. Dietary minerals and colon carcinogenesis (review). Anticancer Res 1987; 7: 259-63.

  7. Williams GM, Weisburger JH. Food and cancer: cause and effect? Surg Clin North Am 1986; 66: 873-89.

  8. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, et al. Randomized, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107, 349 subjects. Lancet 1989; 1: 1160-4.

  9. Winawer SJ, Miller C, Lightdale C, Herbert E, Ephram RC, Gordon L, et al. Patient response to sigmoidoscopy: A randomized, controlled trial of rigid and flexible sigmoidoscopy. Cancer 1987; 60: 1905-8.

  10. American Society of Colon and Rectal Surgeons. 89th Annual Convention Poster Presentations and Abstracts. 1990 Apr 29 - May 4; St. Louis, Missouri. Ballantyne GH, Savoca PE, Fleming FX. Screening Colonoscopy in asymptomatic patients (Abstract 44). Dis Colon Rectum 1990; 33: P14-5.

  11. Northover JMA. Staging and management of colorectal cancer. World J Surg 1997; 21: 672-7.

  12. Nogueras JJ, Jagelman DG. Principles of surgical resection. Influence of surgical technique on treatment outcome. Surg Clin North Am 1993; 73: 103-16.

  13. Enker WE. Sphincter-preserving operations for rectal cancer. Oncology (Huntingt) 1996; 10: 1673-84, 1689; discussion 1690-2.

  14. Cummings BJ. Radiation therapy for colorectal cancer. Surg Clin North Am 1993; 73: 167-81.

  15. Levitan N. Chemotherapy in colorectal carcinoma. Surg Clin North Am 1993; 73: 183-98.

  16. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA. Cancer J Clin 1999; 49: 3-31,1.

  17. Tovar-Guzmán V, Flores-Aldana M, Salmerón-Castro J, Lazcano-Ponce EC. Epidemiologic panorama of colorectal cancer in Mexico, 1980-1993. Dis Colon Rectum 1998; 41: 225-31.

  18. León-Rodriguez E, Hernández CM. Cáncer de colon en el Instituto Nacional de la Nutrición. I. Resultados de tratamiento de 1979 a 1989. Rev Invest Clin 1996; 48: 191-8.

  19. Luna Pérez P, Reyna Huelga A, Rodríguez Coria DF, Medrano R, González Macouzet J. Cancer colorrectal. Rev Gastroenterol Mex 1997; 62: 175-83.

  20. Medina González S ¿Qué hay de nuevo en cáncer colorrectal? Cir Gen 1999; 21: 41-4.

  21. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444-50.

  22. Moertel CG, Fleming TR, Mcdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 332: 352-58.

  23. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995; 122: 321-6.

  24. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 1993; 11: 1879-87.

  25. Erlichman C, Marsoni S, Seitz JF. Event-free and overall survival is increased by FUFA in resected B and C colon cancer: a prospective pooled analysis of 3 randomized trials (RCTS). Pro ASCO 1994; 13: 14.

  26. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465-72.

  27. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-15.

  28. O´Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-7.




2020     |     www.medigraphic.com